APP and early-onset autosomal dominant Alzheimer disease: Menden et al. [22] showed that administering CL to APP/PS1 mice (Alzheimer’s disease mouse model) not only increased the fecal abundances of beneficial microbiota, such as Acetatifactor and Clostridiales, but also reduced the Alzheimer’s disease-like pathology.